trending Market Intelligence /marketintelligence/en/news-insights/trending/yikmorrik4eafzp1ov2wiw2 content esgSubNav
In This List

Provention Bio appoints director

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Provention Bio appoints director

Provention Bio Inc. added Avery Catlin to its board.

Catlin was previously the senior vice president and CFO of Celldex Therapeutics Inc., a Hampton, N.J.-based biopharmaceutical company that develops immunotherapy technologies and other cancer-targeting biologics.

Oldwick, N.J.-based Provention Bio develops and commercializes novel therapeutics to treat and prevent immune-mediated diseases.